Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$64.19 -0.60 (-0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Short-term Investments (2011 - 2026)

Updated

Arrowhead Pharmaceuticals (ARWR) recorded Short-term Investments of $1.55 billion in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 100.8% from $770.58 million a year earlier but down 3.0% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Short-term Investments (2011 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals reported Short-term Investments of $692.82 million, up 19.8% from FY2024.

  • Annual Short-term Investments has increased for six straight fiscal years, with a five-year compound annual growth rate of 51.5% (FY2020 to FY2025).
  • Across earlier fiscal years, Short-term Investments came in at $578.28 million in FY2024 (+97.5%), $292.74 million in FY2023 (+9.1%), $268.39 million in FY2022 (+111.8%) and $126.73 million in FY2021 (+45.8%).
  • Quarterly Short-term Investments has ranged from $126.01 million in fiscal Q1 2022 to $1.6 billion in fiscal Q2 2026 over the past five years.
  • On a year-over-year basis, Short-term Investments has increased for ten consecutive quarters, with growth averaging 98.1% over the last eight quarters.
  • Peak year-over-year performance for Short-term Investments in the last five years was growth of 207.9% in fiscal Q1 2025, against a decline of 45.9% in fiscal Q1 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $1.6 billion (Q2 2026), $715 million (Q1 2026) and $692.82 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Arrowhead Pharmaceuticals 9.06 Bn 3.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.55 Bn
Mar 31, 2026 1.60 Bn
Dec 31, 2025 715.00 Mn
Sep 30, 2025 692.82 Mn
Jun 30, 2025 770.58 Mn
Mar 31, 2025 911.70 Mn
Dec 31, 2024 499.05 Mn
Sep 30, 2024 578.28 Mn
Jun 30, 2024 367.30 Mn
Mar 31, 2024 395.41 Mn
Dec 31, 2023 162.10 Mn
Sep 30, 2023 292.74 Mn
Jun 30, 2023 346.40 Mn
Mar 31, 2023 346.05 Mn
Dec 31, 2022 299.60 Mn
Sep 30, 2022 268.39 Mn
Jun 30, 2022 277.10 Mn
Mar 31, 2022 192.91 Mn
Dec 31, 2021 126.01 Mn
Sep 30, 2021 126.73 Mn
API Access

Arrowhead Pharmaceuticals Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=ARWR&period=max&api_key=YOUR_API_KEY